Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Anti-TNF-? formula enhances wound healing
Washington - Topical application of anti-tumor necrosis factor-? (TNF-?) monoclonal antibody (infliximab) produced dramatic improvement with wound closure in chronic, non-healing leg ulcers, said Markus Streit, M.D., department of dermatology, Inselspital, Bern, Switzerland.
Related Videos
Related Content
